Anavex Life Sciences
AVXL
59 hedge funds and large institutions have $39.7M invested in Anavex Life Sciences in 2019 Q2 according to their latest regulatory filings, with 14 funds opening new positions, 20 increasing their positions, 12 reducing their positions, and 11 closing their positions.
76% more capital invested
Capital invested by funds: $22.5M → $39.7M (+$17.1M)
67% more repeat investments, than reductions
Existing positions increased: 20 | Existing positions reduced: 12
27% more first-time investments, than exits
New positions opened: 14 | Existing positions closed: 11
7.8% more ownership
Funds ownership: 15.54% → 23.35% (+7.8%)
5% more funds holding
Funds holding: 56 → 59 (+3)
83% less call options, than puts
Call options by funds: $233K | Put options by funds: $1.38M
Top Buyers
| 1 |
BlackRock
New York
|
+$8.03M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$3.66M |
| 3 |
State Street
Boston,
Massachusetts
|
+$1.81M |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$692K |
| 5 |
Jane Street
New York
|
+$403K |
Top Sellers
AVXL Hedge Fund Activity: Q2 2019 in Review
59 of the 4,604 institutional investors tracked by Wall St. Rank reported a position in Anavex Life Sciences (AVXL) for Q2 2019, worth a combined $39.7M — up 76% from $22.5M a quarter earlier.
Buyers outnumbered sellers: 14 funds opened new AVXL positions and 11 closed out — a net gain of 3 holders — while 20 added to existing stakes and 12 trimmed.
The largest buyer was BlackRock, adding an estimated $8.03M. The largest seller was Park West Asset Management, cutting an estimated $1.54M.
- 59 institutional investors held Anavex Life Sciences (AVXL) as of Q2 2019, up from 56 in Q1 2019.
- Funds reported $39.7M of Anavex Life Sciences stock for Q2 2019, up 76% quarter-over-quarter.
- 14 funds opened new Anavex Life Sciences positions in Q2 2019 and 11 closed out, a net change of +3 holders.
- The largest Anavex Life Sciences buyer in Q2 2019 was BlackRock, an estimated $8.03M added.
- The largest Anavex Life Sciences seller in Q2 2019 was Park West Asset Management, an estimated $1.54M sold.
Based on aggregated 13F filings for Q2 2019.